MARSHALL WACE, LLP - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$2,934,000
-99.0%
19,406
-99.0%
0.01%
-99.0%
Q2 2022$281,021,000
-1.3%
1,928,624
-19.7%
0.58%
+7.2%
Q1 2022$284,720,000
-26.2%
2,401,284
-14.2%
0.54%
-24.3%
Q4 2021$385,657,000
+2.1%
2,798,457
+3.0%
0.71%
-54.6%
Q3 2021$377,583,000
+42.3%
2,718,185
-0.5%
1.57%
+30.7%
Q2 2021$265,259,000
+39.8%
2,732,368
-1.6%
1.20%
+37.9%
Q1 2021$189,771,000
-13.4%
2,776,467
+8.6%
0.87%
-26.7%
Q4 2020$219,121,000
+33.3%
2,556,552
+1.1%
1.19%
+12.8%
Q3 2020$164,335,000
-10.1%
2,527,850
+1.1%
1.05%
-17.9%
Q2 2020$182,880,000
+109.6%
2,501,444
-2.4%
1.28%
+47.1%
Q1 2020$87,234,000
+539.5%
2,563,443
+923.1%
0.87%
+826.6%
Q4 2019$13,640,000
-39.2%
250,562
-53.4%
0.09%
-46.6%
Q3 2019$22,437,000
+79.2%
537,797
+88.1%
0.18%
+70.9%
Q2 2019$12,522,000
+1615.3%
285,961
+1914.4%
0.10%
+3333.3%
Q1 2019$730,00014,1960.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$107,867,00052.60%
Knoll Capital Management, LLC 856,844$83,182,00043.44%
ORACLE INVESTMENT MANAGEMENT INC 2,082,555$202,174,00027.86%
ARS Investment Partners, LLC 558,286$54,198,0005.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$17,113,0004.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 401,006$38,930,0004.51%
Eventide Asset Management 1,990,797$193,267,0002.60%
SILVERARC CAPITAL MANAGEMENT, LLC 56,626$5,497,0002.45%
Avidity Partners Management LP 882,500$85,673,0002.32%
Nicholas Investment Partners, LP 363,708$35,309,0002.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders